Cost-Utility of Routine Endometrial Evaluation Prior to Le Fort Colpocleisis by Kandadai, Padma et al.
University of Massachusetts Medical School 
eScholarship@UMMS 
UMass Center for Clinical and Translational 
Science Research Retreat 
2012 UMass Center for Clinical and 
Translational Science Research Retreat 
May 22nd, 4:30 PM - 6:00 PM 
Cost-Utility of Routine Endometrial Evaluation Prior to Le Fort 
Colpocleisis 
Padma Kandadai 
University of Massachusetts Medical School 
Et al. 
Let us know how access to this document benefits you. 
Follow this and additional works at: https://escholarship.umassmed.edu/cts_retreat 
 Part of the Obstetrics and Gynecology Commons 
Kandadai P, Flynn MK, Zweizig S, Patterson D. (2012). Cost-Utility of Routine Endometrial Evaluation Prior 
to Le Fort Colpocleisis. UMass Center for Clinical and Translational Science Research Retreat. Retrieved 
from https://escholarship.umassmed.edu/cts_retreat/2012/posters/34 
Creative Commons License 
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 3.0 License. 
This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in UMass Center for 
Clinical and Translational Science Research Retreat by an authorized administrator of eScholarship@UMMS. For 
more information, please contact Lisa.Palmer@umassmed.edu. 
1 
 
COST-UTILITY OF ROUTINE ENDOMETRIAL EVALUATION PRIOR TO LE FORT COLPOCLEISIS 
 
Padma Kandadai1 MD; Michael Flynn1 MD, MHS; Susan Zweizig2 MD; Danielle Patterson1 MD, MSc 
 
1University of Massachusetts Memorial Medical Center, Department of Obstetrics and Gynecology, 
Division of Urogynecology and Reconstructive Pelvic Surgery; 2University of Massachusetts Memorial 
Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology 
 
Contact Author: Padma Kandadai; Padmasini.kandadai@umassmemorial.org 
 
 
Objective:  Endometrial evaluation is routinely performed in elderly women undergoing Le Fort 
colpocleisis.  There is little evidence to support this practice.  We sought to investigate the cost-utility of 
routine evaluation of the uterine cavity prior to performing a Le Fort colpocleisis. 
 
Study Design:  A decision analysis model was created to compare uterine evaluation, by either 
endometrial biopsy or transvaginal ultrasound, to no evaluation for a cohort of women > 80 years old 
undergoing Le Fort colpocleisis.  Baseline assumptions for our model were made to reflect women who 
did not carry significant risk for the development of endometrial cancer, such as history of 
postmenopausal bleeding, abnormal uterine pathology, obesity, diabetes, and tamoxifen use.  Decision 
paths included no screening, ultrasound evaluation, and biopsy.  The horizon was five years until the 
endpoint of survival, death, or the development of cancer.  Those pathways in which cancer was 
diagnosed were carried out to the endpoint of either five-year survival or death.  Treatment arms for 
endometrial cancer were based on management methods used at our institution.  Probabilities and 
utilities for health outcomes were estimated through literature review or, when unavailable, by expert 
opinion.  Costs were obtained from US Medicare charges for the appropriate CPT and DRG codes and 
are reported in 2012 US Dollars.  Cost-utility analysis was performed using US recommendations from a 
societal perspective.  Sensitivity analysis using Monte Carlo simulation was performed to test the validity 
of our model. 
 
Results:  Analysis of our decision tree demonstrates that a strategy of no evaluation is superior to that of 
either biopsy or ultrasound.  Univariate sensitivity analysis demonstrates that at a 0.55 probability of 
cancer, biopsy surpasses both no evaluation and ultrasound as the dominant strategy.  Using Monte 
Carlo simulation, at willingness-to-pay thresholds of $50,000 and $100,000, no evaluation was superior 
to both biopsy and ultrasound from the patient, health-plan, and societal perspectives.  Biopsy appears 
to be a more effective strategy than ultrasound when uterine evaluation is needed. 
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Conclusions:  Our model shows that a practice of not evaluating the endometrial cavity prior to 
performing Le Fort colpocleisis is superior to either biopsy or ultrasound.  These results are likely being 
driven by the low incidence of endometrial cancer in this population.  It may not be necessary to 
perform uterine evaluation prior to Le Fort colpocleisis in a low-risk population.  If uterine evaluation is 
needed, biopsy appears to be the preferred strategy over ultrasound.  More studies are needed to 
determine utility values for health states experienced by women with pelvic organ prolapse and with 
endometrial cancer.  This will enhance our ability to develop more accurate cost-utility models for 
treating these women. 
